Announcements Trials
Browse Landscape

Phase

Phase NA 15Phase 1 3Phase 2 2Phase 1/2 2Phase 3 1

Status

Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Urinary Bladder Neoplasms 1Sarcoma 1Rhabdomyosarcoma 1Glioma 1Glioblastoma 1Carcinoma in Situ 1Astrocytoma 1

Interventions

Specimen Handling 146pembrolizumab 118Magnetic Resonance Spectroscopy 117Cyclophosphamide 113Biopsy 96fludarabine 88Nivolumab 52Carboplatin 51Cisplatin 47Gemcitabine 46Radiotherapy 41venetoclax 40Cetuximab 40fludarabine phosphate 39Paclitaxel 39Ipilimumab 34atezolizumab 33Fluorouracil 33Bevacizumab 32Oxaliplatin 27Leucovorin 27Dexamethasone 26durvalumab 25X-Rays 25Irinotecan 25Radiation 24Cytarabine 23Azacitidine 23Injections 22Temozolomide 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × Magnetic Resonance Imaging × 90 days × Clear all
NCT07223034 2026-06-04

A Study of 177Lu-PSMA-617 in People With Gliomas

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
20 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma

NCT03054792 2026-04-29

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

The Hospital for Sick Children

Phase 1 Enrolling by invitation
18 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
15 enrolled 21 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡